The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characterization of patients with recurrent glioblastoma in trials involving CED and non-CED treatment.
 
Lisa G. Ensign
Other Relationship - Medidata Solutions, Inc
 
Denis Boisvert
No Relationships to Disclose
 
Norman David LaFrance
Employment - Plus Therapeutics
Leadership - Plus Therapeutics
Stock and Other Ownership Interests - In a trust
Patents, Royalties, Other Intellectual Property - Jubliant; Plus Therapeutics
 
Jacob Hendershot
No Relationships to Disclose
 
Joel Michalek
Travel, Accommodations, Expenses - Plus Therapeutics
 
Andrew J. Brenner
Leadership - NanoTX
Stock and Other Ownership Interests - NanoTX; Plus Therapeutics
Honoraria - Seagen; Vascular Biogenics
Consulting or Advisory Role - Alamab Therapeutics; NanoTX; Plus Therapeutics; Vascular Biogenics
Research Funding - Gilead Sciences (Inst); Immunomedics (Inst); Plus Therapeutics (Inst); Upsher-Smith (Inst)
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Ruthanna Davi
Other Relationship - Medidata Solutions, Inc